Monthly Archives: January 2022

Parkinson's Disease Specific treatment for a Parkinson's disease will be determined by yourdoctor based on: Your age, overall health, and medical history Extent of the condition Type of condition Your tolerance for specific medications, procedures, or therapies Expectations for the course of the condition Your opinion or preference With today's medicine, we have yet to find a cure for Parkinson's disease. However, based on the severity of the symptoms and medical profile, the doctor will establish an appropriate treatment protocol. Treatment for Parkinson's disease may include the following: Medications Surgery Complementary and supportive therapies, such as diet, exercise, physical therapy, occupational therapy, and speech therapy [6 Medication-Free Ways to Feel Better with Parkinsons Disease] Once the doctor diagnoses Parkinsons disease, the next decision is whether a patient should receive medication, which depends on the following: The degree of functional impairment The degree of cognitive impairment Ability to tolerate antiparkinsonian medication The advice of the attending doctor No two patients react the same way to a given drug, therefore, it takes time and patience to find an appropriate medication and dosage to alleviate symptoms Continue reading →

Importance: Parkinson disease is the most common form of parkinsonism, a group of neurological disorders with Parkinson disease-like movement problems such as rigidity, slowness, and tremor. More than 6 million individuals worldwide have Parkinson disease Continue reading →

Parkinsons disease is a progressive disorder of the nervous system. It affects a persons movement and mental ability, with the symptoms getting worse over time. Today, most people with Parkinsons disease will live as long, or almost as long, as those without the disease Continue reading →

A new treatment for life-robbing Parkinsons disease is set to be trialled in Sydney following reports of good results using light therapy. Results from a previous light therapy trial in Adelaide published in the BMC Neurology journal, showed enhanced senses and improved cognition, mood and sleep, mobility, balance, and fine motor skills among patients. Watch the video above to find out how the new life-changing technology uses waves of light to treat Parkinsons sufferer Margaret Jarrett The SYMBYX trial conducted with Parkinsons SA, used the light therapy known as photobiomodulation (PBM) on two small groups of patients, all diagnosed with Parkinsons disease. Continue reading →

PHILADELPHIA, Jan. 11, 2022 (GLOBE NEWSWIRE) -- EnterinInc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company pioneering novel treatments for neurodegenerative and metabolic diseases, announces the publication of a paper entitled "Alpha-synuclein, the culprit in Parkinson's Disease, is required for normal immune function." Alpha-synuclein (S), the pathologic protein associated with Parkinson's Disease (PD), appears to be essential for the immune protection of the abdominal cavity.Furthermore, infections in the GI tract can cause accumulation ofSwithin the entire nervous system, potentially contributing to the development and/or progression of PD,according to scientists at the National Institutes of Health (NIH) and their colleagues, the founders of Enterin, Inc Continue reading →

The superior Parkinsons Disease Treatment market analysis report contains all the company profiles of the major players and brands. Continue reading →